- Zacks
AstraZeneca (AZN) Plans to Generate $80B in Revenues by 2030
AstraZeneca (AZN) targets $80 billion in total revenues by 2030. It expects to launch 20 new medicines.
- Investing.com
Midday movers: Microsoft, Xpeng rise; Palo Alto, Keysight fall
(Updated - May 21, 2024 11:56 AM EDT)
- The Guardian
AstraZeneca aims to nearly double revenues to $80bn by 2030
UK’s biggest drugmaker says it plans to launch 20 major new medicines before the end of the decade
© 2024 Yahoo. All rights reserved.